nodes	percent_of_prediction	percent_of_DWPC	metapath
Tadalafil—CYP3A4—Oxcarbazepine—epilepsy syndrome	0.0473	0.0879	CbGbCtD
Tadalafil—CYP3A4—Felbamate—epilepsy syndrome	0.044	0.0817	CbGbCtD
Tadalafil—CYP3A4—Trimethadione—epilepsy syndrome	0.044	0.0817	CbGbCtD
Tadalafil—CYP3A4—Fosphenytoin—epilepsy syndrome	0.0413	0.0768	CbGbCtD
Tadalafil—CYP3A4—Clonazepam—epilepsy syndrome	0.0374	0.0694	CbGbCtD
Tadalafil—CYP3A4—Clobazam—epilepsy syndrome	0.0358	0.0666	CbGbCtD
Tadalafil—CYP3A4—Rufinamide—epilepsy syndrome	0.0305	0.0566	CbGbCtD
Tadalafil—CYP3A4—Carbamazepine—epilepsy syndrome	0.0297	0.0552	CbGbCtD
Tadalafil—CYP3A4—Primidone—epilepsy syndrome	0.0277	0.0515	CbGbCtD
Tadalafil—CYP3A4—Phenytoin—epilepsy syndrome	0.0266	0.0495	CbGbCtD
Tadalafil—CYP3A4—Propofol—epilepsy syndrome	0.0248	0.0462	CbGbCtD
Tadalafil—CYP3A4—Acetazolamide—epilepsy syndrome	0.0237	0.0441	CbGbCtD
Tadalafil—CYP3A4—Phenobarbital—epilepsy syndrome	0.0237	0.0441	CbGbCtD
Tadalafil—CYP3A4—Midazolam—epilepsy syndrome	0.0234	0.0435	CbGbCtD
Tadalafil—CYP3A4—Diazepam—epilepsy syndrome	0.0225	0.0418	CbGbCtD
Tadalafil—CYP3A4—Zonisamide—epilepsy syndrome	0.022	0.0408	CbGbCtD
Tadalafil—CYP3A4—Valproic Acid—epilepsy syndrome	0.0177	0.033	CbGbCtD
Tadalafil—CYP3A4—Topiramate—epilepsy syndrome	0.016	0.0297	CbGbCtD
Tadalafil—PDE11A—Signaling by GPCR—CHRM3—epilepsy syndrome	0.000212	0.00193	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—GRM5—epilepsy syndrome	0.000212	0.00193	CbGpPWpGaD
Tadalafil—PDE5A—Hemostasis—NOS1—epilepsy syndrome	0.000209	0.0019	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—CCR10—epilepsy syndrome	0.000209	0.0019	CbGpPWpGaD
Tadalafil—PDE11A—GPCR downstream signaling—HRH3—epilepsy syndrome	0.000205	0.00186	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—CX3CR1—epilepsy syndrome	0.000204	0.00185	CbGpPWpGaD
Tadalafil—PDE11A—GPCR downstream signaling—OPRM1—epilepsy syndrome	0.000202	0.00184	CbGpPWpGaD
Tadalafil—PDE11A—Hemostasis—CDC42—epilepsy syndrome	0.000201	0.00183	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—BDKRB1—epilepsy syndrome	0.0002	0.00182	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—CX3CL1—epilepsy syndrome	0.0002	0.00182	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—CHRM2—epilepsy syndrome	0.0002	0.00182	CbGpPWpGaD
Tadalafil—PDE5A—Hemostasis—AKT3—epilepsy syndrome	0.000196	0.00178	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—GABBR1—epilepsy syndrome	0.000194	0.00177	CbGpPWpGaD
Tadalafil—PDE5A—Hemostasis—PLAUR—epilepsy syndrome	0.000194	0.00176	CbGpPWpGaD
Tadalafil—PDE11A—GPCR downstream signaling—CCR3—epilepsy syndrome	0.000191	0.00173	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—HRH3—epilepsy syndrome	0.000186	0.00169	CbGpPWpGaD
Tadalafil—PDE11A—GPCR downstream signaling—NPY—epilepsy syndrome	0.000186	0.00169	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—OPRM1—epilepsy syndrome	0.000183	0.00167	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—GRM2—epilepsy syndrome	0.000183	0.00166	CbGpPWpGaD
Tadalafil—PDE11A—GPCR downstream signaling—CRH—epilepsy syndrome	0.000179	0.00163	CbGpPWpGaD
Tadalafil—PDE11A—GPCR downstream signaling—OXT—epilepsy syndrome	0.000179	0.00163	CbGpPWpGaD
Tadalafil—PDE11A—GPCR downstream signaling—CXCL2—epilepsy syndrome	0.000179	0.00163	CbGpPWpGaD
Tadalafil—PDE5A—Hemostasis—CDC42—epilepsy syndrome	0.000179	0.00163	CbGpPWpGaD
Tadalafil—PDE11A—Hemostasis—FYN—epilepsy syndrome	0.000179	0.00163	CbGpPWpGaD
Tadalafil—CYP3A4—Metapathway biotransformation—KCNAB2—epilepsy syndrome	0.000174	0.00158	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—CCR3—epilepsy syndrome	0.000173	0.00157	CbGpPWpGaD
Tadalafil—PDE11A—Hemostasis—YWHAZ—epilepsy syndrome	0.000172	0.00156	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—NPY—epilepsy syndrome	0.000169	0.00153	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—SSTR3—epilepsy syndrome	0.000166	0.00151	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—OXT—epilepsy syndrome	0.000163	0.00148	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—CRH—epilepsy syndrome	0.000163	0.00148	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—CXCL2—epilepsy syndrome	0.000163	0.00148	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—CCL3—epilepsy syndrome	0.000163	0.00148	CbGpPWpGaD
Tadalafil—PDE11A—GPCR downstream signaling—SST—epilepsy syndrome	0.000162	0.00147	CbGpPWpGaD
Tadalafil—PDE11A—GPCR downstream signaling—CCR2—epilepsy syndrome	0.000162	0.00147	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—ST3GAL3—epilepsy syndrome	0.000162	0.00147	CbGpPWpGaD
Tadalafil—PDE5A—Hemostasis—FYN—epilepsy syndrome	0.000159	0.00145	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—ARHGEF9—epilepsy syndrome	0.000159	0.00144	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—CCR9—epilepsy syndrome	0.000159	0.00144	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—SSTR1—epilepsy syndrome	0.000159	0.00144	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—CCR8—epilepsy syndrome	0.000159	0.00144	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—NPY2R—epilepsy syndrome	0.000159	0.00144	CbGpPWpGaD
Tadalafil—PDE11A—GPCR downstream signaling—ADRA2A—epilepsy syndrome	0.000159	0.00144	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—GRM3—epilepsy syndrome	0.000156	0.00142	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—GRM4—epilepsy syndrome	0.000156	0.00142	CbGpPWpGaD
Tadalafil—PDE5A—Hemostasis—YWHAZ—epilepsy syndrome	0.000153	0.00139	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—DUSP4—epilepsy syndrome	0.000153	0.00139	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—SSTR2—epilepsy syndrome	0.000153	0.00139	CbGpPWpGaD
Tadalafil—PDE11A—Hemostasis—PLAU—epilepsy syndrome	0.000153	0.00139	CbGpPWpGaD
Tadalafil—PDE11A—GPCR downstream signaling—CXCL12—epilepsy syndrome	0.000152	0.00139	CbGpPWpGaD
Tadalafil—PDE11A—GPCR downstream signaling—BDKRB2—epilepsy syndrome	0.000152	0.00139	CbGpPWpGaD
Tadalafil—PDE11A—GPCR downstream signaling—CNR1—epilepsy syndrome	0.00015	0.00136	CbGpPWpGaD
Tadalafil—PDE11A—GPCR downstream signaling—PLCB1—epilepsy syndrome	0.000149	0.00136	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—GRM8—epilepsy syndrome	0.000148	0.00134	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—PGF—epilepsy syndrome	0.000148	0.00134	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—CCR2—epilepsy syndrome	0.000147	0.00134	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—SST—epilepsy syndrome	0.000147	0.00134	CbGpPWpGaD
Tadalafil—PDE11A—GPCR downstream signaling—HTR7—epilepsy syndrome	0.000146	0.00133	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—ADRA2A—epilepsy syndrome	0.000144	0.00131	CbGpPWpGaD
Tadalafil—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—epilepsy syndrome	0.000143	0.0013	CbGpPWpGaD
Tadalafil—PDE11A—Hemostasis—PRKCB—epilepsy syndrome	0.000142	0.00129	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—OPRD1—epilepsy syndrome	0.000141	0.00128	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—GNAO1—epilepsy syndrome	0.000141	0.00128	CbGpPWpGaD
Tadalafil—PDE11A—Hemostasis—NOS2—epilepsy syndrome	0.00014	0.00127	CbGpPWpGaD
Tadalafil—PDE11A—GPCR downstream signaling—AKT3—epilepsy syndrome	0.000139	0.00126	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—CXCL12—epilepsy syndrome	0.000138	0.00126	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—BDKRB2—epilepsy syndrome	0.000138	0.00126	CbGpPWpGaD
Tadalafil—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—epilepsy syndrome	0.000137	0.00124	CbGpPWpGaD
Tadalafil—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—epilepsy syndrome	0.000136	0.00124	CbGpPWpGaD
Tadalafil—PDE5A—Hemostasis—PLAU—epilepsy syndrome	0.000136	0.00124	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—CNR1—epilepsy syndrome	0.000136	0.00124	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—PLCB1—epilepsy syndrome	0.000135	0.00123	CbGpPWpGaD
Tadalafil—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2C19—epilepsy syndrome	0.000135	0.00123	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—CCR7—epilepsy syndrome	0.000135	0.00123	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—PDYN—epilepsy syndrome	0.000135	0.00123	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—GRM1—epilepsy syndrome	0.000135	0.00123	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—CHRM1—epilepsy syndrome	0.000135	0.00123	CbGpPWpGaD
Tadalafil—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP11A1—epilepsy syndrome	0.000135	0.00122	CbGpPWpGaD
Tadalafil—CYP3A4—Oxidation by Cytochrome P450—CYP2C19—epilepsy syndrome	0.000134	0.00121	CbGpPWpGaD
Tadalafil—CYP3A4—Oxidation by Cytochrome P450—CYP11A1—epilepsy syndrome	0.000133	0.00121	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—HTR7—epilepsy syndrome	0.000133	0.00121	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—HBEGF—epilepsy syndrome	0.000129	0.00117	CbGpPWpGaD
Tadalafil—PDE11A—GPCR downstream signaling—CDC42—epilepsy syndrome	0.000127	0.00115	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—GFAP—epilepsy syndrome	0.000127	0.00115	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—GAL—epilepsy syndrome	0.000127	0.00115	CbGpPWpGaD
Tadalafil—PDE5A—Hemostasis—PRKCB—epilepsy syndrome	0.000126	0.00115	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—AKT3—epilepsy syndrome	0.000126	0.00115	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—CHRM3—epilepsy syndrome	0.000125	0.00114	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—CASP2—epilepsy syndrome	0.000125	0.00114	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—GRM5—epilepsy syndrome	0.000125	0.00114	CbGpPWpGaD
Tadalafil—PDE5A—Hemostasis—NOS2—epilepsy syndrome	0.000125	0.00114	CbGpPWpGaD
Tadalafil—Nervous system disorder—Valproic Acid—epilepsy syndrome	0.000124	0.000352	CcSEcCtD
Tadalafil—Palpitations—Pregabalin—epilepsy syndrome	0.000124	0.000351	CcSEcCtD
Tadalafil—Asthenia—Phenytoin—epilepsy syndrome	0.000124	0.000351	CcSEcCtD
Tadalafil—Nausea—Midazolam—epilepsy syndrome	0.000123	0.00035	CcSEcCtD
Tadalafil—Hypoaesthesia—Topiramate—epilepsy syndrome	0.000123	0.00035	CcSEcCtD
Tadalafil—Muscle spasms—Gabapentin—epilepsy syndrome	0.000123	0.00035	CcSEcCtD
Tadalafil—Tachycardia—Valproic Acid—epilepsy syndrome	0.000123	0.00035	CcSEcCtD
Tadalafil—Diarrhoea—Zonisamide—epilepsy syndrome	0.000123	0.00035	CcSEcCtD
Tadalafil—Pharyngitis—Topiramate—epilepsy syndrome	0.000123	0.00035	CcSEcCtD
Tadalafil—Loss of consciousness—Pregabalin—epilepsy syndrome	0.000123	0.000349	CcSEcCtD
Tadalafil—Asthenia—Oxcarbazepine—epilepsy syndrome	0.000123	0.000349	CcSEcCtD
Tadalafil—PDE11A—GPCR downstream signaling—AVP—epilepsy syndrome	0.000123	0.00112	CbGpPWpGaD
Tadalafil—Pruritus—Clonazepam—epilepsy syndrome	0.000123	0.000349	CcSEcCtD
Tadalafil—Vomiting—Vigabatrin—epilepsy syndrome	0.000123	0.000348	CcSEcCtD
Tadalafil—Skin disorder—Valproic Acid—epilepsy syndrome	0.000123	0.000348	CcSEcCtD
Tadalafil—Urinary tract disorder—Topiramate—epilepsy syndrome	0.000122	0.000348	CcSEcCtD
Tadalafil—Oedema peripheral—Topiramate—epilepsy syndrome	0.000122	0.000347	CcSEcCtD
Tadalafil—Hyperhidrosis—Valproic Acid—epilepsy syndrome	0.000122	0.000347	CcSEcCtD
Tadalafil—Cough—Pregabalin—epilepsy syndrome	0.000122	0.000347	CcSEcCtD
Tadalafil—Pruritus—Phenytoin—epilepsy syndrome	0.000122	0.000346	CcSEcCtD
Tadalafil—Connective tissue disorder—Topiramate—epilepsy syndrome	0.000122	0.000346	CcSEcCtD
Tadalafil—Nausea—Levetiracetam—epilepsy syndrome	0.000122	0.000346	CcSEcCtD
Tadalafil—Rash—Vigabatrin—epilepsy syndrome	0.000122	0.000346	CcSEcCtD
Tadalafil—Dizziness—Felbamate—epilepsy syndrome	0.000122	0.000345	CcSEcCtD
Tadalafil—Dermatitis—Vigabatrin—epilepsy syndrome	0.000121	0.000345	CcSEcCtD
Tadalafil—Urethral disorder—Topiramate—epilepsy syndrome	0.000121	0.000345	CcSEcCtD
Tadalafil—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2D6—epilepsy syndrome	0.000121	0.0011	CbGpPWpGaD
Tadalafil—Pruritus—Oxcarbazepine—epilepsy syndrome	0.000121	0.000344	CcSEcCtD
Tadalafil—Convulsion—Pregabalin—epilepsy syndrome	0.000121	0.000344	CcSEcCtD
Tadalafil—Hypersensitivity—Carbamazepine—epilepsy syndrome	0.000121	0.000344	CcSEcCtD
Tadalafil—Vision blurred—Gabapentin—epilepsy syndrome	0.000121	0.000343	CcSEcCtD
Tadalafil—Headache—Vigabatrin—epilepsy syndrome	0.000121	0.000343	CcSEcCtD
Tadalafil—Hypertension—Pregabalin—epilepsy syndrome	0.000121	0.000343	CcSEcCtD
Tadalafil—Vomiting—Diazepam—epilepsy syndrome	0.000121	0.000343	CcSEcCtD
Tadalafil—PDE11A—Signaling Pathways—CX3CR1—epilepsy syndrome	0.00012	0.00109	CbGpPWpGaD
Tadalafil—CYP3A4—Oxidation by Cytochrome P450—CYP2D6—epilepsy syndrome	0.00012	0.00109	CbGpPWpGaD
Tadalafil—Rash—Diazepam—epilepsy syndrome	0.00012	0.00034	CcSEcCtD
Tadalafil—Dermatitis—Diazepam—epilepsy syndrome	0.00012	0.00034	CcSEcCtD
Tadalafil—Arthralgia—Pregabalin—epilepsy syndrome	0.000119	0.000338	CcSEcCtD
Tadalafil—Chest pain—Pregabalin—epilepsy syndrome	0.000119	0.000338	CcSEcCtD
Tadalafil—Myalgia—Pregabalin—epilepsy syndrome	0.000119	0.000338	CcSEcCtD
Tadalafil—Dizziness—Zonisamide—epilepsy syndrome	0.000119	0.000338	CcSEcCtD
Tadalafil—Headache—Diazepam—epilepsy syndrome	0.000119	0.000338	CcSEcCtD
Tadalafil—Diarrhoea—Clonazepam—epilepsy syndrome	0.000119	0.000337	CcSEcCtD
Tadalafil—Unspecified disorder of skin and subcutaneous tissue—Pregabalin—epilepsy syndrome	0.000118	0.000336	CcSEcCtD
Tadalafil—PDE11A—Signaling Pathways—BDKRB1—epilepsy syndrome	0.000118	0.00107	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—CX3CL1—epilepsy syndrome	0.000118	0.00107	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—CHRM2—epilepsy syndrome	0.000118	0.00107	CbGpPWpGaD
Tadalafil—Hypotension—Valproic Acid—epilepsy syndrome	0.000118	0.000335	CcSEcCtD
Tadalafil—Asthenia—Carbamazepine—epilepsy syndrome	0.000118	0.000335	CcSEcCtD
Tadalafil—Diarrhoea—Phenytoin—epilepsy syndrome	0.000118	0.000335	CcSEcCtD
Tadalafil—PDE11A—Hemostasis—ALB—epilepsy syndrome	0.000118	0.00107	CbGpPWpGaD
Tadalafil—Discomfort—Pregabalin—epilepsy syndrome	0.000118	0.000334	CcSEcCtD
Tadalafil—Nausea—Fosphenytoin—epilepsy syndrome	0.000118	0.000334	CcSEcCtD
Tadalafil—Diarrhoea—Oxcarbazepine—epilepsy syndrome	0.000117	0.000333	CcSEcCtD
Tadalafil—Erythema multiforme—Topiramate—epilepsy syndrome	0.000117	0.000333	CcSEcCtD
Tadalafil—Angioedema—Gabapentin—epilepsy syndrome	0.000117	0.000333	CcSEcCtD
Tadalafil—Hypersensitivity—Lamotrigine—epilepsy syndrome	0.000117	0.000333	CcSEcCtD
Tadalafil—Vomiting—Felbamate—epilepsy syndrome	0.000117	0.000332	CcSEcCtD
Tadalafil—Dry mouth—Pregabalin—epilepsy syndrome	0.000116	0.000331	CcSEcCtD
Tadalafil—Pruritus—Carbamazepine—epilepsy syndrome	0.000116	0.000331	CcSEcCtD
Tadalafil—Rash—Felbamate—epilepsy syndrome	0.000116	0.000329	CcSEcCtD
Tadalafil—Eye disorder—Topiramate—epilepsy syndrome	0.000116	0.000329	CcSEcCtD
Tadalafil—Dermatitis—Felbamate—epilepsy syndrome	0.000116	0.000329	CcSEcCtD
Tadalafil—Tinnitus—Topiramate—epilepsy syndrome	0.000116	0.000328	CcSEcCtD
Tadalafil—PDE11A—Signaling by GPCR—CDC42—epilepsy syndrome	0.000115	0.00105	CbGpPWpGaD
Tadalafil—Vertigo—Gabapentin—epilepsy syndrome	0.000115	0.000327	CcSEcCtD
Tadalafil—Headache—Felbamate—epilepsy syndrome	0.000115	0.000327	CcSEcCtD
Tadalafil—Musculoskeletal discomfort—Valproic Acid—epilepsy syndrome	0.000115	0.000327	CcSEcCtD
Tadalafil—Flushing—Topiramate—epilepsy syndrome	0.000115	0.000327	CcSEcCtD
Tadalafil—Cardiac disorder—Topiramate—epilepsy syndrome	0.000115	0.000327	CcSEcCtD
Tadalafil—Syncope—Gabapentin—epilepsy syndrome	0.000115	0.000327	CcSEcCtD
Tadalafil—PDE11A—Signaling Pathways—GABBR1—epilepsy syndrome	0.000115	0.00104	CbGpPWpGaD
Tadalafil—Dizziness—Clonazepam—epilepsy syndrome	0.000115	0.000326	CcSEcCtD
Tadalafil—Nausea—Vigabatrin—epilepsy syndrome	0.000115	0.000326	CcSEcCtD
Tadalafil—Vomiting—Zonisamide—epilepsy syndrome	0.000114	0.000325	CcSEcCtD
Tadalafil—Insomnia—Valproic Acid—epilepsy syndrome	0.000114	0.000324	CcSEcCtD
Tadalafil—Oedema—Pregabalin—epilepsy syndrome	0.000114	0.000324	CcSEcCtD
Tadalafil—Asthenia—Lamotrigine—epilepsy syndrome	0.000114	0.000324	CcSEcCtD
Tadalafil—Dizziness—Phenytoin—epilepsy syndrome	0.000114	0.000324	CcSEcCtD
Tadalafil—Rash—Zonisamide—epilepsy syndrome	0.000113	0.000322	CcSEcCtD
Tadalafil—Infection—Pregabalin—epilepsy syndrome	0.000113	0.000322	CcSEcCtD
Tadalafil—Paraesthesia—Valproic Acid—epilepsy syndrome	0.000113	0.000322	CcSEcCtD
Tadalafil—Palpitations—Gabapentin—epilepsy syndrome	0.000113	0.000322	CcSEcCtD
Tadalafil—Dermatitis—Zonisamide—epilepsy syndrome	0.000113	0.000322	CcSEcCtD
Tadalafil—Dizziness—Oxcarbazepine—epilepsy syndrome	0.000113	0.000322	CcSEcCtD
Tadalafil—Nausea—Diazepam—epilepsy syndrome	0.000113	0.000321	CcSEcCtD
Tadalafil—Loss of consciousness—Gabapentin—epilepsy syndrome	0.000113	0.00032	CcSEcCtD
Tadalafil—Headache—Zonisamide—epilepsy syndrome	0.000113	0.00032	CcSEcCtD
Tadalafil—Dyspnoea—Valproic Acid—epilepsy syndrome	0.000113	0.00032	CcSEcCtD
Tadalafil—Diarrhoea—Carbamazepine—epilepsy syndrome	0.000112	0.00032	CcSEcCtD
Tadalafil—Angiopathy—Topiramate—epilepsy syndrome	0.000112	0.00032	CcSEcCtD
Tadalafil—Pruritus—Lamotrigine—epilepsy syndrome	0.000112	0.000319	CcSEcCtD
Tadalafil—Shock—Pregabalin—epilepsy syndrome	0.000112	0.000319	CcSEcCtD
Tadalafil—Somnolence—Valproic Acid—epilepsy syndrome	0.000112	0.000319	CcSEcCtD
Tadalafil—Immune system disorder—Topiramate—epilepsy syndrome	0.000112	0.000318	CcSEcCtD
Tadalafil—Nervous system disorder—Pregabalin—epilepsy syndrome	0.000112	0.000318	CcSEcCtD
Tadalafil—Cough—Gabapentin—epilepsy syndrome	0.000112	0.000318	CcSEcCtD
Tadalafil—Mediastinal disorder—Topiramate—epilepsy syndrome	0.000112	0.000317	CcSEcCtD
Tadalafil—PDE11A—Signaling by GPCR—AVP—epilepsy syndrome	0.000112	0.00101	CbGpPWpGaD
Tadalafil—Tachycardia—Pregabalin—epilepsy syndrome	0.000111	0.000317	CcSEcCtD
Tadalafil—Dyspepsia—Valproic Acid—epilepsy syndrome	0.000111	0.000316	CcSEcCtD
Tadalafil—Convulsion—Gabapentin—epilepsy syndrome	0.000111	0.000316	CcSEcCtD
Tadalafil—Skin disorder—Pregabalin—epilepsy syndrome	0.000111	0.000315	CcSEcCtD
Tadalafil—Hypertension—Gabapentin—epilepsy syndrome	0.000111	0.000315	CcSEcCtD
Tadalafil—Hyperhidrosis—Pregabalin—epilepsy syndrome	0.00011	0.000314	CcSEcCtD
Tadalafil—CYP3A4—Tryptophan metabolism—CAT—epilepsy syndrome	0.00011	0.001	CbGpPWpGaD
Tadalafil—Vomiting—Clonazepam—epilepsy syndrome	0.00011	0.000313	CcSEcCtD
Tadalafil—PDE11A—Signaling Pathways—HRH3—epilepsy syndrome	0.00011	0.001	CbGpPWpGaD
Tadalafil—CYP3A4—Phase 1 - Functionalization of compounds—CYP2C19—epilepsy syndrome	0.00011	0.000998	CbGpPWpGaD
Tadalafil—Vomiting—Phenytoin—epilepsy syndrome	0.000109	0.000311	CcSEcCtD
Tadalafil—Rash—Clonazepam—epilepsy syndrome	0.000109	0.000311	CcSEcCtD
Tadalafil—Dermatitis—Clonazepam—epilepsy syndrome	0.000109	0.00031	CcSEcCtD
Tadalafil—Myalgia—Gabapentin—epilepsy syndrome	0.000109	0.00031	CcSEcCtD
Tadalafil—Arthralgia—Gabapentin—epilepsy syndrome	0.000109	0.00031	CcSEcCtD
Tadalafil—Chest pain—Gabapentin—epilepsy syndrome	0.000109	0.00031	CcSEcCtD
Tadalafil—Nausea—Felbamate—epilepsy syndrome	0.000109	0.00031	CcSEcCtD
Tadalafil—CYP3A4—Phase 1 - Functionalization of compounds—CYP11A1—epilepsy syndrome	0.000109	0.000992	CbGpPWpGaD
Tadalafil—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	0.000109	0.00031	CcSEcCtD
Tadalafil—Vomiting—Oxcarbazepine—epilepsy syndrome	0.000109	0.00031	CcSEcCtD
Tadalafil—Fatigue—Valproic Acid—epilepsy syndrome	0.000109	0.000309	CcSEcCtD
Tadalafil—Dizziness—Carbamazepine—epilepsy syndrome	0.000109	0.000309	CcSEcCtD
Tadalafil—Diarrhoea—Lamotrigine—epilepsy syndrome	0.000109	0.000309	CcSEcCtD
Tadalafil—Headache—Clonazepam—epilepsy syndrome	0.000109	0.000309	CcSEcCtD
Tadalafil—Rash—Phenytoin—epilepsy syndrome	0.000109	0.000309	CcSEcCtD
Tadalafil—Mental disorder—Topiramate—epilepsy syndrome	0.000109	0.000309	CcSEcCtD
Tadalafil—Dermatitis—Phenytoin—epilepsy syndrome	0.000108	0.000308	CcSEcCtD
Tadalafil—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—epilepsy syndrome	0.000108	0.000308	CcSEcCtD
Tadalafil—PDE11A—Signaling Pathways—OPRM1—epilepsy syndrome	0.000108	0.000985	CbGpPWpGaD
Tadalafil—Rash—Oxcarbazepine—epilepsy syndrome	0.000108	0.000307	CcSEcCtD
Tadalafil—Pain—Valproic Acid—epilepsy syndrome	0.000108	0.000307	CcSEcCtD
Tadalafil—Constipation—Valproic Acid—epilepsy syndrome	0.000108	0.000307	CcSEcCtD
Tadalafil—Dermatitis—Oxcarbazepine—epilepsy syndrome	0.000108	0.000307	CcSEcCtD
Tadalafil—Headache—Phenytoin—epilepsy syndrome	0.000108	0.000307	CcSEcCtD
Tadalafil—Discomfort—Gabapentin—epilepsy syndrome	0.000108	0.000307	CcSEcCtD
Tadalafil—Headache—Oxcarbazepine—epilepsy syndrome	0.000107	0.000305	CcSEcCtD
Tadalafil—Nausea—Zonisamide—epilepsy syndrome	0.000107	0.000304	CcSEcCtD
Tadalafil—Dry mouth—Gabapentin—epilepsy syndrome	0.000107	0.000303	CcSEcCtD
Tadalafil—Hypotension—Pregabalin—epilepsy syndrome	0.000107	0.000303	CcSEcCtD
Tadalafil—Dizziness—Lamotrigine—epilepsy syndrome	0.000105	0.000299	CcSEcCtD
Tadalafil—PDE5A—Hemostasis—ALB—epilepsy syndrome	0.000105	0.000955	CbGpPWpGaD
Tadalafil—Oedema—Gabapentin—epilepsy syndrome	0.000105	0.000297	CcSEcCtD
Tadalafil—Vomiting—Carbamazepine—epilepsy syndrome	0.000104	0.000297	CcSEcCtD
Tadalafil—PDE11A—GPCR downstream signaling—CCR5—epilepsy syndrome	0.000104	0.00095	CbGpPWpGaD
Tadalafil—Back pain—Topiramate—epilepsy syndrome	0.000104	0.000297	CcSEcCtD
Tadalafil—Musculoskeletal discomfort—Pregabalin—epilepsy syndrome	0.000104	0.000295	CcSEcCtD
Tadalafil—Infection—Gabapentin—epilepsy syndrome	0.000104	0.000295	CcSEcCtD
Tadalafil—Muscle spasms—Topiramate—epilepsy syndrome	0.000104	0.000295	CcSEcCtD
Tadalafil—Rash—Carbamazepine—epilepsy syndrome	0.000104	0.000295	CcSEcCtD
Tadalafil—Dermatitis—Carbamazepine—epilepsy syndrome	0.000104	0.000294	CcSEcCtD
Tadalafil—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	0.000103	0.000293	CcSEcCtD
Tadalafil—Insomnia—Pregabalin—epilepsy syndrome	0.000103	0.000293	CcSEcCtD
Tadalafil—Nausea—Clonazepam—epilepsy syndrome	0.000103	0.000293	CcSEcCtD
Tadalafil—Headache—Carbamazepine—epilepsy syndrome	0.000103	0.000293	CcSEcCtD
Tadalafil—Shock—Gabapentin—epilepsy syndrome	0.000103	0.000293	CcSEcCtD
Tadalafil—Nervous system disorder—Gabapentin—epilepsy syndrome	0.000103	0.000292	CcSEcCtD
Tadalafil—Paraesthesia—Pregabalin—epilepsy syndrome	0.000102	0.000291	CcSEcCtD
Tadalafil—PDE11A—Signaling Pathways—CCR3—epilepsy syndrome	0.000102	0.00093	CbGpPWpGaD
Tadalafil—Nausea—Phenytoin—epilepsy syndrome	0.000102	0.000291	CcSEcCtD
Tadalafil—PDE11A—GPCR downstream signaling—HTR2A—epilepsy syndrome	0.000102	0.00093	CbGpPWpGaD
Tadalafil—Tachycardia—Gabapentin—epilepsy syndrome	0.000102	0.00029	CcSEcCtD
Tadalafil—Dyspnoea—Pregabalin—epilepsy syndrome	0.000102	0.000289	CcSEcCtD
Tadalafil—Nausea—Oxcarbazepine—epilepsy syndrome	0.000102	0.000289	CcSEcCtD
Tadalafil—Vision blurred—Topiramate—epilepsy syndrome	0.000102	0.000289	CcSEcCtD
Tadalafil—Skin disorder—Gabapentin—epilepsy syndrome	0.000102	0.000289	CcSEcCtD
Tadalafil—Somnolence—Pregabalin—epilepsy syndrome	0.000101	0.000288	CcSEcCtD
Tadalafil—Hyperhidrosis—Gabapentin—epilepsy syndrome	0.000101	0.000288	CcSEcCtD
Tadalafil—Vomiting—Lamotrigine—epilepsy syndrome	0.000101	0.000287	CcSEcCtD
Tadalafil—Urticaria—Valproic Acid—epilepsy syndrome	0.0001	0.000285	CcSEcCtD
Tadalafil—Rash—Lamotrigine—epilepsy syndrome	0.0001	0.000285	CcSEcCtD
Tadalafil—Dermatitis—Lamotrigine—epilepsy syndrome	0.0001	0.000284	CcSEcCtD
Tadalafil—Abdominal pain—Valproic Acid—epilepsy syndrome	9.98e-05	0.000284	CcSEcCtD
Tadalafil—PDE11A—Signaling Pathways—NPY—epilepsy syndrome	9.97e-05	0.000906	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—ATP2A2—epilepsy syndrome	9.97e-05	0.000906	CbGpPWpGaD
Tadalafil—Headache—Lamotrigine—epilepsy syndrome	9.95e-05	0.000283	CcSEcCtD
Tadalafil—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	9.85e-05	0.00028	CcSEcCtD
Tadalafil—CYP3A4—Phase 1 - Functionalization of compounds—CYP2D6—epilepsy syndrome	9.84e-05	0.000895	CbGpPWpGaD
Tadalafil—Fatigue—Pregabalin—epilepsy syndrome	9.84e-05	0.00028	CcSEcCtD
Tadalafil—Hypotension—Gabapentin—epilepsy syndrome	9.78e-05	0.000278	CcSEcCtD
Tadalafil—Nausea—Carbamazepine—epilepsy syndrome	9.76e-05	0.000277	CcSEcCtD
Tadalafil—Pain—Pregabalin—epilepsy syndrome	9.76e-05	0.000277	CcSEcCtD
Tadalafil—Constipation—Pregabalin—epilepsy syndrome	9.76e-05	0.000277	CcSEcCtD
Tadalafil—PDE11A—GPCR downstream signaling—AGT—epilepsy syndrome	9.7e-05	0.000882	CbGpPWpGaD
Tadalafil—Vertigo—Topiramate—epilepsy syndrome	9.69e-05	0.000275	CcSEcCtD
Tadalafil—Syncope—Topiramate—epilepsy syndrome	9.67e-05	0.000275	CcSEcCtD
Tadalafil—PDE11A—Signaling Pathways—OXT—epilepsy syndrome	9.62e-05	0.000874	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—CRH—epilepsy syndrome	9.62e-05	0.000874	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—CCL3—epilepsy syndrome	9.62e-05	0.000874	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—HSPB1—epilepsy syndrome	9.62e-05	0.000874	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—CXCL2—epilepsy syndrome	9.62e-05	0.000874	CbGpPWpGaD
Tadalafil—Musculoskeletal discomfort—Gabapentin—epilepsy syndrome	9.53e-05	0.000271	CcSEcCtD
Tadalafil—Palpitations—Topiramate—epilepsy syndrome	9.53e-05	0.000271	CcSEcCtD
Tadalafil—PDE11A—Signaling by GPCR—CCR5—epilepsy syndrome	9.49e-05	0.000863	CbGpPWpGaD
Tadalafil—Loss of consciousness—Topiramate—epilepsy syndrome	9.48e-05	0.000269	CcSEcCtD
Tadalafil—Insomnia—Gabapentin—epilepsy syndrome	9.46e-05	0.000269	CcSEcCtD
Tadalafil—Nausea—Lamotrigine—epilepsy syndrome	9.43e-05	0.000268	CcSEcCtD
Tadalafil—Cough—Topiramate—epilepsy syndrome	9.41e-05	0.000268	CcSEcCtD
Tadalafil—Paraesthesia—Gabapentin—epilepsy syndrome	9.4e-05	0.000267	CcSEcCtD
Tadalafil—Convulsion—Topiramate—epilepsy syndrome	9.35e-05	0.000266	CcSEcCtD
Tadalafil—Gastrointestinal pain—Pregabalin—epilepsy syndrome	9.33e-05	0.000265	CcSEcCtD
Tadalafil—Dyspnoea—Gabapentin—epilepsy syndrome	9.33e-05	0.000265	CcSEcCtD
Tadalafil—Hypertension—Topiramate—epilepsy syndrome	9.31e-05	0.000265	CcSEcCtD
Tadalafil—Somnolence—Gabapentin—epilepsy syndrome	9.3e-05	0.000264	CcSEcCtD
Tadalafil—Hypersensitivity—Valproic Acid—epilepsy syndrome	9.3e-05	0.000264	CcSEcCtD
Tadalafil—PDE11A—Signaling by GPCR—HTR2A—epilepsy syndrome	9.28e-05	0.000844	CbGpPWpGaD
Tadalafil—Dyspepsia—Gabapentin—epilepsy syndrome	9.21e-05	0.000262	CcSEcCtD
Tadalafil—Arthralgia—Topiramate—epilepsy syndrome	9.18e-05	0.000261	CcSEcCtD
Tadalafil—Myalgia—Topiramate—epilepsy syndrome	9.18e-05	0.000261	CcSEcCtD
Tadalafil—Chest pain—Topiramate—epilepsy syndrome	9.18e-05	0.000261	CcSEcCtD
Tadalafil—Unspecified disorder of skin and subcutaneous tissue—Topiramate—epilepsy syndrome	9.12e-05	0.000259	CcSEcCtD
Tadalafil—Discomfort—Topiramate—epilepsy syndrome	9.07e-05	0.000258	CcSEcCtD
Tadalafil—Urticaria—Pregabalin—epilepsy syndrome	9.06e-05	0.000258	CcSEcCtD
Tadalafil—Asthenia—Valproic Acid—epilepsy syndrome	9.06e-05	0.000257	CcSEcCtD
Tadalafil—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	9.03e-05	0.000257	CcSEcCtD
Tadalafil—Fatigue—Gabapentin—epilepsy syndrome	9.02e-05	0.000256	CcSEcCtD
Tadalafil—Abdominal pain—Pregabalin—epilepsy syndrome	9.02e-05	0.000256	CcSEcCtD
Tadalafil—Dry mouth—Topiramate—epilepsy syndrome	8.98e-05	0.000255	CcSEcCtD
Tadalafil—PDE11A—GPCR downstream signaling—PRKCB—epilepsy syndrome	8.96e-05	0.000815	CbGpPWpGaD
Tadalafil—Pain—Gabapentin—epilepsy syndrome	8.95e-05	0.000254	CcSEcCtD
Tadalafil—Constipation—Gabapentin—epilepsy syndrome	8.95e-05	0.000254	CcSEcCtD
Tadalafil—PDE11A—Signaling Pathways—TSC1—epilepsy syndrome	8.94e-05	0.000813	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—PTK2B—epilepsy syndrome	8.94e-05	0.000813	CbGpPWpGaD
Tadalafil—Pruritus—Valproic Acid—epilepsy syndrome	8.93e-05	0.000254	CcSEcCtD
Tadalafil—PDE11A—Signaling by GPCR—AGT—epilepsy syndrome	8.81e-05	0.000801	CbGpPWpGaD
Tadalafil—Oedema—Topiramate—epilepsy syndrome	8.8e-05	0.00025	CcSEcCtD
Tadalafil—Infection—Topiramate—epilepsy syndrome	8.75e-05	0.000249	CcSEcCtD
Tadalafil—PDE11A—Signaling Pathways—NTRK2—epilepsy syndrome	8.7e-05	0.000791	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—SST—epilepsy syndrome	8.7e-05	0.000791	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—CCR2—epilepsy syndrome	8.7e-05	0.000791	CbGpPWpGaD
Tadalafil—Shock—Topiramate—epilepsy syndrome	8.66e-05	0.000246	CcSEcCtD
Tadalafil—Diarrhoea—Valproic Acid—epilepsy syndrome	8.64e-05	0.000245	CcSEcCtD
Tadalafil—Nervous system disorder—Topiramate—epilepsy syndrome	8.63e-05	0.000245	CcSEcCtD
Tadalafil—PDE11A—Signaling Pathways—DUSP6—epilepsy syndrome	8.62e-05	0.000784	CbGpPWpGaD
Tadalafil—Tachycardia—Topiramate—epilepsy syndrome	8.59e-05	0.000244	CcSEcCtD
Tadalafil—Gastrointestinal pain—Gabapentin—epilepsy syndrome	8.56e-05	0.000243	CcSEcCtD
Tadalafil—Skin disorder—Topiramate—epilepsy syndrome	8.55e-05	0.000243	CcSEcCtD
Tadalafil—PDE11A—Signaling Pathways—ADRA2A—epilepsy syndrome	8.51e-05	0.000774	CbGpPWpGaD
Tadalafil—Hyperhidrosis—Topiramate—epilepsy syndrome	8.51e-05	0.000242	CcSEcCtD
Tadalafil—PDE11A—Signaling Pathways—PLAT—epilepsy syndrome	8.47e-05	0.000771	CbGpPWpGaD
Tadalafil—Hypersensitivity—Pregabalin—epilepsy syndrome	8.41e-05	0.000239	CcSEcCtD
Tadalafil—Dizziness—Valproic Acid—epilepsy syndrome	8.35e-05	0.000237	CcSEcCtD
Tadalafil—PDE11A—Hemostasis—SRC—epilepsy syndrome	8.33e-05	0.000758	CbGpPWpGaD
Tadalafil—Urticaria—Gabapentin—epilepsy syndrome	8.31e-05	0.000236	CcSEcCtD
Tadalafil—Abdominal pain—Gabapentin—epilepsy syndrome	8.27e-05	0.000235	CcSEcCtD
Tadalafil—Hypotension—Topiramate—epilepsy syndrome	8.23e-05	0.000234	CcSEcCtD
Tadalafil—Asthenia—Pregabalin—epilepsy syndrome	8.19e-05	0.000233	CcSEcCtD
Tadalafil—PDE11A—Signaling Pathways—BDKRB2—epilepsy syndrome	8.18e-05	0.000743	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—CXCL12—epilepsy syndrome	8.18e-05	0.000743	CbGpPWpGaD
Tadalafil—PDE11A—GPCR downstream signaling—POMC—epilepsy syndrome	8.16e-05	0.000742	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—PRKCB—epilepsy syndrome	8.14e-05	0.00074	CbGpPWpGaD
Tadalafil—PDE11A—Hemostasis—VEGFA—epilepsy syndrome	8.12e-05	0.000738	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—IL6ST—epilepsy syndrome	8.11e-05	0.000737	CbGpPWpGaD
Tadalafil—Pruritus—Pregabalin—epilepsy syndrome	8.07e-05	0.000229	CcSEcCtD
Tadalafil—PDE11A—Signaling Pathways—CNR1—epilepsy syndrome	8.03e-05	0.00073	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—JUNB—epilepsy syndrome	8.03e-05	0.00073	CbGpPWpGaD
Tadalafil—Vomiting—Valproic Acid—epilepsy syndrome	8.03e-05	0.000228	CcSEcCtD
Tadalafil—Musculoskeletal discomfort—Topiramate—epilepsy syndrome	8.02e-05	0.000228	CcSEcCtD
Tadalafil—PDE11A—Signaling Pathways—PLCB1—epilepsy syndrome	8e-05	0.000727	CbGpPWpGaD
Tadalafil—Insomnia—Topiramate—epilepsy syndrome	7.96e-05	0.000226	CcSEcCtD
Tadalafil—Rash—Valproic Acid—epilepsy syndrome	7.96e-05	0.000226	CcSEcCtD
Tadalafil—Dermatitis—Valproic Acid—epilepsy syndrome	7.95e-05	0.000226	CcSEcCtD
Tadalafil—Headache—Valproic Acid—epilepsy syndrome	7.91e-05	0.000225	CcSEcCtD
Tadalafil—Paraesthesia—Topiramate—epilepsy syndrome	7.9e-05	0.000225	CcSEcCtD
Tadalafil—Dyspnoea—Topiramate—epilepsy syndrome	7.85e-05	0.000223	CcSEcCtD
Tadalafil—PDE11A—Signaling Pathways—HTR7—epilepsy syndrome	7.83e-05	0.000712	CbGpPWpGaD
Tadalafil—Somnolence—Topiramate—epilepsy syndrome	7.83e-05	0.000222	CcSEcCtD
Tadalafil—Diarrhoea—Pregabalin—epilepsy syndrome	7.81e-05	0.000222	CcSEcCtD
Tadalafil—Dyspepsia—Topiramate—epilepsy syndrome	7.75e-05	0.00022	CcSEcCtD
Tadalafil—Hypersensitivity—Gabapentin—epilepsy syndrome	7.71e-05	0.000219	CcSEcCtD
Tadalafil—PDE11A—Signaling Pathways—HBEGF—epilepsy syndrome	7.6e-05	0.000691	CbGpPWpGaD
Tadalafil—Gastrointestinal disorder—Topiramate—epilepsy syndrome	7.6e-05	0.000216	CcSEcCtD
Tadalafil—Fatigue—Topiramate—epilepsy syndrome	7.59e-05	0.000216	CcSEcCtD
Tadalafil—Dizziness—Pregabalin—epilepsy syndrome	7.55e-05	0.000214	CcSEcCtD
Tadalafil—Pain—Topiramate—epilepsy syndrome	7.53e-05	0.000214	CcSEcCtD
Tadalafil—Constipation—Topiramate—epilepsy syndrome	7.53e-05	0.000214	CcSEcCtD
Tadalafil—Asthenia—Gabapentin—epilepsy syndrome	7.51e-05	0.000213	CcSEcCtD
Tadalafil—Nausea—Valproic Acid—epilepsy syndrome	7.5e-05	0.000213	CcSEcCtD
Tadalafil—PDE11A—Signaling Pathways—AKT3—epilepsy syndrome	7.46e-05	0.000678	CbGpPWpGaD
Tadalafil—PDE5A—Hemostasis—SRC—epilepsy syndrome	7.43e-05	0.000675	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—POMC—epilepsy syndrome	7.41e-05	0.000674	CbGpPWpGaD
Tadalafil—Pruritus—Gabapentin—epilepsy syndrome	7.4e-05	0.00021	CcSEcCtD
Tadalafil—PDE11A—Signaling Pathways—ADAM10—epilepsy syndrome	7.29e-05	0.000663	CbGpPWpGaD
Tadalafil—Vomiting—Pregabalin—epilepsy syndrome	7.26e-05	0.000206	CcSEcCtD
Tadalafil—PDE11A—Signaling by GPCR—CCL2—epilepsy syndrome	7.25e-05	0.00066	CbGpPWpGaD
Tadalafil—PDE5A—Hemostasis—VEGFA—epilepsy syndrome	7.23e-05	0.000658	CbGpPWpGaD
Tadalafil—Gastrointestinal pain—Topiramate—epilepsy syndrome	7.2e-05	0.000205	CcSEcCtD
Tadalafil—Rash—Pregabalin—epilepsy syndrome	7.19e-05	0.000205	CcSEcCtD
Tadalafil—Dermatitis—Pregabalin—epilepsy syndrome	7.19e-05	0.000204	CcSEcCtD
Tadalafil—Diarrhoea—Gabapentin—epilepsy syndrome	7.16e-05	0.000203	CcSEcCtD
Tadalafil—Headache—Pregabalin—epilepsy syndrome	7.15e-05	0.000203	CcSEcCtD
Tadalafil—Urticaria—Topiramate—epilepsy syndrome	6.99e-05	0.000199	CcSEcCtD
Tadalafil—Abdominal pain—Topiramate—epilepsy syndrome	6.96e-05	0.000198	CcSEcCtD
Tadalafil—Dizziness—Gabapentin—epilepsy syndrome	6.92e-05	0.000197	CcSEcCtD
Tadalafil—PDE11A—Signaling Pathways—S100B—epilepsy syndrome	6.89e-05	0.000627	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—SOCS3—epilepsy syndrome	6.82e-05	0.00062	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—CDC42—epilepsy syndrome	6.81e-05	0.000619	CbGpPWpGaD
Tadalafil—Nausea—Pregabalin—epilepsy syndrome	6.78e-05	0.000193	CcSEcCtD
Tadalafil—Vomiting—Gabapentin—epilepsy syndrome	6.65e-05	0.000189	CcSEcCtD
Tadalafil—Rash—Gabapentin—epilepsy syndrome	6.6e-05	0.000188	CcSEcCtD
Tadalafil—Dermatitis—Gabapentin—epilepsy syndrome	6.59e-05	0.000187	CcSEcCtD
Tadalafil—PDE11A—Signaling Pathways—AVP—epilepsy syndrome	6.59e-05	0.000599	CbGpPWpGaD
Tadalafil—Headache—Gabapentin—epilepsy syndrome	6.55e-05	0.000186	CcSEcCtD
Tadalafil—Hypersensitivity—Topiramate—epilepsy syndrome	6.49e-05	0.000184	CcSEcCtD
Tadalafil—Asthenia—Topiramate—epilepsy syndrome	6.32e-05	0.00018	CcSEcCtD
Tadalafil—PDE11A—Signaling Pathways—HES1—epilepsy syndrome	6.23e-05	0.000567	CbGpPWpGaD
Tadalafil—Pruritus—Topiramate—epilepsy syndrome	6.23e-05	0.000177	CcSEcCtD
Tadalafil—Nausea—Gabapentin—epilepsy syndrome	6.22e-05	0.000177	CcSEcCtD
Tadalafil—PDE11A—Signaling Pathways—FYN—epilepsy syndrome	6.06e-05	0.000551	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—H2AFX—epilepsy syndrome	6.04e-05	0.000549	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—MEF2C—epilepsy syndrome	6.03e-05	0.000548	CbGpPWpGaD
Tadalafil—Diarrhoea—Topiramate—epilepsy syndrome	6.02e-05	0.000171	CcSEcCtD
Tadalafil—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—epilepsy syndrome	5.95e-05	0.000541	CbGpPWpGaD
Tadalafil—CYP3A4—Biological oxidations—CYP2C19—epilepsy syndrome	5.83e-05	0.00053	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—YWHAZ—epilepsy syndrome	5.83e-05	0.00053	CbGpPWpGaD
Tadalafil—Dizziness—Topiramate—epilepsy syndrome	5.82e-05	0.000165	CcSEcCtD
Tadalafil—CYP3A4—Biological oxidations—CYP11A1—epilepsy syndrome	5.79e-05	0.000527	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—NGF—epilepsy syndrome	5.76e-05	0.000524	CbGpPWpGaD
Tadalafil—CYP3A4—Metapathway biotransformation—CYP2C19—epilepsy syndrome	5.75e-05	0.000523	CbGpPWpGaD
Tadalafil—CYP3A4—Metapathway biotransformation—CYP11A1—epilepsy syndrome	5.71e-05	0.000519	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—CCR5—epilepsy syndrome	5.6e-05	0.00051	CbGpPWpGaD
Tadalafil—Vomiting—Topiramate—epilepsy syndrome	5.6e-05	0.000159	CcSEcCtD
Tadalafil—Rash—Topiramate—epilepsy syndrome	5.55e-05	0.000158	CcSEcCtD
Tadalafil—Dermatitis—Topiramate—epilepsy syndrome	5.55e-05	0.000158	CcSEcCtD
Tadalafil—Headache—Topiramate—epilepsy syndrome	5.51e-05	0.000157	CcSEcCtD
Tadalafil—PDE11A—Signaling Pathways—HTR2A—epilepsy syndrome	5.48e-05	0.000499	CbGpPWpGaD
Tadalafil—Nausea—Topiramate—epilepsy syndrome	5.23e-05	0.000149	CcSEcCtD
Tadalafil—CYP3A4—Biological oxidations—CYP2D6—epilepsy syndrome	5.23e-05	0.000475	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—TSC2—epilepsy syndrome	5.21e-05	0.000474	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—AGT—epilepsy syndrome	5.2e-05	0.000473	CbGpPWpGaD
Tadalafil—PDE11A—Hemostasis—AKT1—epilepsy syndrome	5.18e-05	0.000471	CbGpPWpGaD
Tadalafil—CYP3A4—Metapathway biotransformation—CYP2D6—epilepsy syndrome	5.16e-05	0.000469	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—APOE—epilepsy syndrome	5.1e-05	0.000464	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—KDR—epilepsy syndrome	4.99e-05	0.000454	CbGpPWpGaD
Tadalafil—CYP3A4—Phase 1 - Functionalization of compounds—POMC—epilepsy syndrome	4.82e-05	0.000438	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—PRKCB—epilepsy syndrome	4.81e-05	0.000437	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—IL6ST—epilepsy syndrome	4.79e-05	0.000435	CbGpPWpGaD
Tadalafil—PDE5A—Hemostasis—AKT1—epilepsy syndrome	4.62e-05	0.00042	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—POMC—epilepsy syndrome	4.38e-05	0.000398	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—CCL2—epilepsy syndrome	4.29e-05	0.00039	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—CA13—epilepsy syndrome	3.99e-05	0.000363	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—FGF2—epilepsy syndrome	3.87e-05	0.000352	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—RELA—epilepsy syndrome	3.6e-05	0.000327	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—MTOR—epilepsy syndrome	3.53e-05	0.000321	CbGpPWpGaD
Tadalafil—PDE11A—GPCR downstream signaling—AKT1—epilepsy syndrome	3.27e-05	0.000298	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—CASP3—epilepsy syndrome	3.24e-05	0.000295	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—JUN—epilepsy syndrome	3.15e-05	0.000286	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—MMP9—epilepsy syndrome	3.06e-05	0.000279	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—GLUD1—epilepsy syndrome	3.02e-05	0.000275	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—PDXK—epilepsy syndrome	3.02e-05	0.000275	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—CERS1—epilepsy syndrome	3.02e-05	0.000275	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—FAR1—epilepsy syndrome	3.02e-05	0.000275	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—ADK—epilepsy syndrome	3.02e-05	0.000275	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—L2HGDH—epilepsy syndrome	3.02e-05	0.000275	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—AKT1—epilepsy syndrome	2.97e-05	0.00027	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—SRC—epilepsy syndrome	2.83e-05	0.000257	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—GAMT—epilepsy syndrome	2.76e-05	0.000251	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—NHLRC1—epilepsy syndrome	2.76e-05	0.000251	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—EPM2A—epilepsy syndrome	2.76e-05	0.000251	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—PNPO—epilepsy syndrome	2.76e-05	0.000251	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—VEGFA—epilepsy syndrome	2.75e-05	0.00025	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—CA4—epilepsy syndrome	2.57e-05	0.000234	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—QDPR—epilepsy syndrome	2.57e-05	0.000234	CbGpPWpGaD
Tadalafil—CYP3A4—Biological oxidations—POMC—epilepsy syndrome	2.56e-05	0.000233	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—COX3—epilepsy syndrome	2.42e-05	0.00022	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—PFKL—epilepsy syndrome	2.29e-05	0.000208	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—SLCO1A2—epilepsy syndrome	2.29e-05	0.000208	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—CACNA2D2—epilepsy syndrome	2.29e-05	0.000208	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—KCNB1—epilepsy syndrome	2.29e-05	0.000208	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—SLC6A8—epilepsy syndrome	2.29e-05	0.000208	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—NEU1—epilepsy syndrome	2.09e-05	0.00019	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—UPB1—epilepsy syndrome	2.09e-05	0.00019	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—ATIC—epilepsy syndrome	2.09e-05	0.00019	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—HSD17B4—epilepsy syndrome	2.02e-05	0.000183	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—PPP1R3C—epilepsy syndrome	1.95e-05	0.000177	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—GBE1—epilepsy syndrome	1.95e-05	0.000177	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—ASAH1—epilepsy syndrome	1.83e-05	0.000166	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—STXBP1—epilepsy syndrome	1.78e-05	0.000162	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—AKT1—epilepsy syndrome	1.76e-05	0.00016	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—NT5E—epilepsy syndrome	1.74e-05	0.000158	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—ALAD—epilepsy syndrome	1.74e-05	0.000158	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—CACNA1A—epilepsy syndrome	1.66e-05	0.000151	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—ALDH7A1—epilepsy syndrome	1.66e-05	0.000151	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—ST3GAL3—epilepsy syndrome	1.62e-05	0.000147	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—ADSL—epilepsy syndrome	1.59e-05	0.000144	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—GLUL—epilepsy syndrome	1.56e-05	0.000142	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—CACNA1D—epilepsy syndrome	1.53e-05	0.000139	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—TXNRD1—epilepsy syndrome	1.43e-05	0.00013	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—AQP1—epilepsy syndrome	1.39e-05	0.000126	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—KCNJ11—epilepsy syndrome	1.25e-05	0.000114	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—CHRM3—epilepsy syndrome	1.25e-05	0.000114	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—ABCG2—epilepsy syndrome	1.02e-05	9.3e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—CYP2C19—epilepsy syndrome	9.97e-06	9.06e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—CYP11A1—epilepsy syndrome	9.91e-06	9.01e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—CYP2D6—epilepsy syndrome	8.94e-06	8.13e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—ADRA2A—epilepsy syndrome	8.51e-06	7.74e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—BCHE—epilepsy syndrome	8.48e-06	7.71e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—SLC2A1—epilepsy syndrome	8.09e-06	7.35e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—PLCB1—epilepsy syndrome	8e-06	7.27e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—TH—epilepsy syndrome	7.97e-06	7.25e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—HMOX1—epilepsy syndrome	6.65e-06	6.05e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—CAT—epilepsy syndrome	6.56e-06	5.97e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—ABCB1—epilepsy syndrome	6.38e-06	5.8e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—GPX1—epilepsy syndrome	5.93e-06	5.4e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—AGT—epilepsy syndrome	5.2e-06	4.73e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—APOE—epilepsy syndrome	5.1e-06	4.64e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—POMC—epilepsy syndrome	4.38e-06	3.98e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—ALB—epilepsy syndrome	3.99e-06	3.63e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—PTGS2—epilepsy syndrome	3.49e-06	3.18e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—AKT1—epilepsy syndrome	1.76e-06	1.6e-05	CbGpPWpGaD
